United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - cyproheptadine hydrochloride - oral tablet - 4mg

United States - English - NLM (National Library of Medicine)

zydus lifesciences limited - cyproheptadine hydrochloride (unii: nj82j0f8qc) (cyproheptadine - unii:2yhb6175do) - perennial and seasonal allergic rhinitis vasomotor rhinitis allergic conjunctivitis due to inhalant allergens and foods mild, uncomplicated allergic skin manifestations of urticaria and angioedema amelioration of allergic reactions to blood or plasma cold urticaria dermatographism as therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the cute manifestations have been controlled. this drug should not be used in newborn or premature infants. because of the higher risk of antihistamines for infants generally and for newborns and prematures in particular, antihistamine therapy is contraindicated in nursing mothers. hypersensitivity to cyproheptadine and other drugs of similar chemical structure. monoamine oxidase inhibitor therapy (see drug int eract ions. ) angle-closure glaucoma stenosing peptic ulcer symptomatic prostatic hypertrophy bladder neck obstruction pyloroduodenal obstruction elderly, debilitated patients

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - cyproheptadine hydrochloride sesquihydrate, quantity: 4.3 mg (equivalent: cyproheptadine hydrochloride, qty 4 mg) - tablet, uncoated - excipient ingredients: calcium hydrogen phosphate dihydrate; magnesium stearate; pregelatinised maize starch; lactose monohydrate; maize starch - use as an antiallergic-antipruritic agent and relief of migraine and vascular types of headaches.

Canada - English - Health Canada

jamp pharma corporation - cyproheptadine hydrochloride - tablet - 4mg - cyproheptadine hydrochloride 4mg - miscellaneous derivatives

Canada - English - Health Canada

euro-pharm international canada inc - cyproheptadine hydrochloride - syrup - 2mg - cyproheptadine hydrochloride 2mg - miscellaneous derivatives

Canada - English - Health Canada

euro-pharm international canada inc - cyproheptadine hydrochloride - tablet - 4mg - cyproheptadine hydrochloride 4mg - miscellaneous derivatives

Canada - English - Health Canada

marcan pharmaceuticals inc - cyproheptadine hydrochloride - tablet - 4mg - cyproheptadine hydrochloride 4mg

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - cyproheptadine hydrochloride (unii: nj82j0f8qc) (cyproheptadine - unii:2yhb6175do) - perennial and seasonal allergic rhinitis vasomotor rhinitis allergic conjunctivitis due to inhalant allergens and foods mild, uncomplicated allergic skin manifestations of urticaria and angioedema amelioration of allergic reactions to blood or plasma cold urticaria dermatographism as therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the acute manifestations have been controlled. newborn or premature infants: this drug should not be used in newborn or premature infants. nursing mothers: because of the higher risk of antihistamines for infants generally and for newborns and prematures in particular, antihistamine therapy is contraindicated in nursing mothers. other conditions: hypersensitivity to cyproheptadine and other drugs of similar chemical structure monoamine oxidase inhibitor therapy (see drug interactions) angle-closure glaucoma stenosing peptic ulcer symptomatic prostatic hypertrophy bladder neck obstruction pyloroduodenal ob

Kenya - English - Pharmacy and Poisons Board

til healthcare pvt ltd “jhaver centre”, rajah annamalai building, 72, - cyproheptadine hydrochloride (anhydrous), … - syrup - each 5 ml contains : cyproheptadine hydrochloride… - other antihistamines for systemic use

Canada - English - Health Canada

sandoz canada incorporated - cyproheptadine hydrochloride - tablet - 4mg - cyproheptadine hydrochloride 4mg - miscellaneous derivatives